Allergan Inc. To Request California Federal Court Block Valeant Pharmaceuticals International And Pershing Square From Voting Shares Acquired In Violation Of Insider Trading Laws

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) announced today that it has asked the United States District Court for the Central District of California to set an expedited schedule for discovery and a motion for a preliminary injunction against Valeant Pharmaceuticals (NYSE: VRX) (“Valeant”), Pershing Square Capital Management, L.P. (“Pershing Square”), and its principal, William A. Ackman, for violations of the federal securities laws. In addition, Allergan announced that it will hold a Special Meeting of Stockholders (the “Special Meeting”) on December 18, 2014, subject to confirmation by Allergan that the meeting has been validly requested in compliance with Allergan’s bylaws. Allergan has established an October 27, 2014 record date for stockholders entitled to vote at the Special Meeting.

Help employers find you! Check out all the jobs and post your resume.